Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
GlaxoSmithKline
National Cancer Institute (NCI)
Klus Pharma Inc.
Quadriga Biosciences, Inc.
Stanford University
Merck Sharp & Dohme LLC